Literature DB >> 23206502

Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid β(1-42).

Helena Janíčková1, Vladimír Rudajev, Pavel Zimčík, Jan Jakubík, Heikki Tanila, Esam E El-Fakahany, Vladimír Doležal.   

Abstract

The overproduction of β-amyloid (Aβ) fragments in transgenic APPswe/PS1dE9 mice results in formation of amyloid deposits in the cerebral cortex and hippocampus starting around four months of age and leading to cognitive impairment much later. We have previously found an age and transgene-dependent weakening of muscarinic receptor-mediated transmission that was not present in young (6-10-week-old) animals but preceded both amyloid deposits and cognitive deficits. Now we investigated immediate and prolonged in vitro effects of non-aggregated Aβ(1-42) on coupling of individual muscarinic receptor subtypes expressed in CHO (Chinese hamster ovary) cells and their underlying mechanisms. Immediate application of 1 μM Aβ(1-42) had no effect on the binding of the muscarinic antagonist N-methylscopolamine or the agonist carbachol. In contrast, 4-day treatment of CHO cells expressing the M1 muscarinic receptor with 100 nM Aβ(1-42) significantly changed the binding characteristics of the muscarinic agonist carbachol and reduced the extent of the M1 receptor-stimulated breakdown of phosphatidylinositol while it did not demonstrate overt toxic effects. The treatment had no influence on the expression of either G-proteins or muscarinic receptors. In concert, we found no change in the gene expression of muscarinic receptor subtypes and gene or protein expression of the G(s), G(q/11), and G(i/o) G-proteins in the cerebral cortex of young adult APPswe/PS1dE9 mice that demonstrate high concentrations of soluble Aβ(1-42) and impaired muscarinic receptor-mediated G-protein activation. Our results provide strong evidence that the initial injurious effects of Aβ(1-42) on M1 muscarinic receptor-mediated transmissionis is due to compromised coupling of the receptor with G(q/11) G-protein.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23206502     DOI: 10.1016/j.neuropharm.2012.11.014

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  16 in total

1.  Chronic Administration of Scopolamine Increased GSK3βP9, Beta Secretase, Amyloid Beta, and Oxidative Stress in the Hippocampus of Wistar Rats.

Authors:  Maricarmen Hernández-Rodríguez; Ivonne Maciel Arciniega-Martínez; Iohanan Daniel García-Marín; José Correa-Basurto; Martha Cecilia Rosales-Hernández
Journal:  Mol Neurobiol       Date:  2020-07-07       Impact factor: 5.590

2.  Local cholinergic-GABAergic circuitry within the basal forebrain is modulated by galanin.

Authors:  Joanne C Damborsky; Kathleen G Smith; Patricia Jensen; Jerrel L Yakel
Journal:  Brain Struct Funct       Date:  2016-08-05       Impact factor: 3.270

3.  Nicotinic and muscarinic agonists and acetylcholinesterase inhibitors stimulate a common pathway to enhance GluN2B-NMDAR responses.

Authors:  Masaru Ishibashi; Yoshihiko Yamazaki; Ricardo Miledi; Katumi Sumikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

Review 4.  Cholinergic modulation of the hippocampal region and memory function.

Authors:  Juhee Haam; Jerrel L Yakel
Journal:  J Neurochem       Date:  2017-08       Impact factor: 5.372

5.  EP3 receptor isoforms are differentially expressed in subpopulations of primate granulosa cells and couple to unique G-proteins.

Authors:  Soon Ok Kim; Brandy L Dozier; Julie A Kerry; Diane M Duffy
Journal:  Reproduction       Date:  2013-10-21       Impact factor: 3.906

Review 6.  M1 muscarinic acetylcholine receptor in Alzheimer's disease.

Authors:  Shangtong Jiang; Yanfang Li; Cuilin Zhang; Yingjun Zhao; Guojun Bu; Huaxi Xu; Yun-Wu Zhang
Journal:  Neurosci Bull       Date:  2014-03-03       Impact factor: 5.203

7.  Noradrenergic sympathetic sprouting and cholinergic reinnervation maintains non-amyloidogenic processing of AβPP.

Authors:  Amy R Nelson; Krystyna Kolasa; Lori L McMahon
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 8.  GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease.

Authors:  Mauricio O Nava-Mesa; Lydia Jiménez-Díaz; Javier Yajeya; Juan D Navarro-Lopez
Journal:  Front Cell Neurosci       Date:  2014-06-25       Impact factor: 5.505

9.  Amyloid-β(25-35) Modulates the Expression of GirK and KCNQ Channel Genes in the Hippocampus.

Authors:  Jennifer Mayordomo-Cava; Javier Yajeya; Juan D Navarro-López; Lydia Jiménez-Díaz
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

10.  Amyloid Beta peptides differentially affect hippocampal theta rhythms in vitro.

Authors:  Armando I Gutiérrez-Lerma; Benito Ordaz; Fernando Peña-Ortega
Journal:  Int J Pept       Date:  2013-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.